uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate
H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA..
Cedars Sinai Med Ctr, Samuel Oschin Canc Ctr, Carcinoid Neuroendocrine Tumor Program, Los Angeles, CA 90048 USA..
Univ Kentucky, Markey Canc Ctr, Lexington, KY USA..
Dana Farber Canc Inst, Boston, MA 02115 USA..
Show others and affiliations
2016 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 27, 121-121 p.Article in journal, Meeting abstract (Other academic) PublishedText
Place, publisher, year, edition, pages
2016. Vol. 27, 121-121 p.
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-301135ISI: 000379756200392OAI: oai:DiVA.org:uu-301135DiVA: diva2:955174
18th World Congress of the European-Society-for-Medical-Oncology (ESMO) on Gastrointestinal Cancer, JUN 29-JUL 02, 2016, Barcelona, SPAIN

Supplement: 2, Meeting Abstract: O-009

Available from: 2016-08-24 Created: 2016-08-18 Last updated: 2016-08-24Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Öberg, Kjell
By organisation
Endocrine oncology
In the same journal
Annals of Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 29 hits
ReferencesLink to record
Permanent link

Direct link